Y-box binding protein 1 augments sorafenib resistance via the PI3K/Akt signaling pathway in hepatocellular carcinoma.
Liu T, Xie XL, Zhou X, Chen SX, Wang YJ, Shi LP, Chen SJ, Wang YJ, Wang SL, Zhang JN, Dou SY, Jiang XY, Cui RL, Jiang HQ.
Liu T, et al. Among authors: chen sx, chen sj.
World J Gastroenterol. 2021 Jul 28;27(28):4667-4686. doi: 10.3748/wjg.v27.i28.4667.
World J Gastroenterol. 2021.
PMID: 34366628
Free PMC article.